Innovation and translation are at the forefront of work at LSTM as it aims to discover and develop, then go forward with implementation of its innovative ideas. In doing so, LSTM considers itself unique in spanning the translational pipeline from discovery to implementation.
Latest
-
News article Transmission risk of COVID-19 from sports equipment Transmission risk of COVID-19 from sports equipment A team, led by Liverpool School of Tropical Medicine's Dr Emily Adams, has investigated the transmission risk of COVID-19 from sports equipment,...
-
News article Dr Fiona Marston becomes LSTM’s Entrepreneur in Residence Dr Fiona Marston becomes LSTM’s Entrepreneur in Residence Dr Fiona Marston is to become LSTM’s Entrepreneur in Residence after being awarded a place on the Royal Society’s scheme for 2021.
-
News article Volunteer for the COM COV Clinical Trial Volunteer for the COM COV Clinical Trial COM COV Clinical Trial Oxford Vaccine Group at LSTM
Comparing COVID-19 Vaccine Schedule Combinations (Pfizer and Astra Zeneca) -
News article World's first COVID-19 vaccine alternating dose study launches in Liverpool World's first COVID-19 vaccine alternating dose study launches in Liverpool COVID-19 vaccine alternating dose study launched today in the UK
Study will examine using different vaccines for the two... -
News article LSTM researchers investigate the impact of pneumococcal colonisation on immune responses to live attenuated influenza vaccine LSTM researchers investigate the impact of pneumococcal colonisation on immune responses to live attenuated influenza vaccine LSTM researchers, led by Dr Elena Mitsi, have investigated the impact of pneumococcal colonisation on immune responses to live attenuated influenza...
-
News article Excalibur rapid SARS-COV-2 antigen screening test, validated by LSTM, granted MHRA approval Excalibur rapid SARS-COV-2 antigen screening test, validated by LSTM, granted MHRA approval Excalibur Healthcare Services Ltd, a UK-based provider of high-quality medical products and services, has announced that its Rapid SARS COV-2 Antigen...
-
News article Mologic Receives CE Mark Approval for Professional-Use COVID-19 Rapid Antigen Test Mologic Receives CE Mark Approval for Professional-Use COVID-19 Rapid Antigen Test
-
News article New spray, co-developed with the British Army and tested by LSTM, kills coronavirus in under 60 seconds New spray, co-developed with the British Army and tested by LSTM, kills coronavirus in under 60 seconds An Essex inventor working alongside the British Army has created a ‘military grade’ disinfectant spray, tested by LSTM, which kills all coronavirus...
-
News article Drug combination protects mice from the lethal effects of snakebite caused by geographically diverse snake species Drug combination protects mice from the lethal effects of snakebite caused by geographically diverse snake species Researchers at LSTM’s Centre for Snakebite Research and Interventions (CSRI) have found that a combination of toxin inhibitors could provide the...
-
News article Oxford Covid vaccine 'safe and effective', Lancet study shows Oxford Covid vaccine 'safe and effective', Lancet study shows Vaccine researchers at LSTM want to say a huge thank you to all of the participants and volunteers who took part in the Phase III Oxford COVID-19...
-
News article LSTM Annual Report and Financial Statements 2019-2020 LSTM Annual Report and Financial Statements 2019-2020 The LSTM Annual Report and Financial Statements 2019-2020 are now available
-
News article First partner meeting of iiCON, the Infection Innovation Consortium First partner meeting of iiCON, the Infection Innovation Consortium The new multimillion-pound Infection Innovation Consortium (iiCON), had its initial partner meeting, setting the agenda of their work over the next...
-
News article LSTM partner in national ‘Decade of Health’ campaign LSTM partner in national ‘Decade of Health’ campaign LSTM is proud to be a part of a new campaign funded by the Bill & Melinda Gates Foundation which highlights the research being carried out in the...
-
News article LSTM researchers find an easy alternative to nasal and throat swabbing for SARS-CoV-2 Diagnosis LSTM researchers find an easy alternative to nasal and throat swabbing for SARS-CoV-2 Diagnosis Researchers from LSTM, working alongside clinical and research staff at the Royal Liverpool and Aintree University Hospitals, have found that saliva...
-
News article LSTM's third virtual symposium on Global Health Research & Vaccination: Private sector partnership, research and accelerating the development of new tools LSTM's third virtual symposium on Global Health Research & Vaccination: Private sector partnership, research and accelerating the development of new tools LSTM hosted the last in a series of online symposia that addressed the role of research in vaccine development and delivery and the creation of...
-
News article LSTM named as a site for Phase III of the Oxford COVID-19 vaccine human trials LSTM named as a site for Phase III of the Oxford COVID-19 vaccine human trials LSTM has begun recruiting frontline health and social care workers to take part in a COVID-19 vaccine trial.
-
News article LSTM announces the recipients of the Director’s Catalyst Fund (DCF) 2020 LSTM announces the recipients of the Director’s Catalyst Fund (DCF) 2020 LSTM’s Director’s Catalyst Fund (DCF) 2020 awards have been selected. This year, six awards will be allocated to early career researchers pursuing...
-
News article LSTM & World Immunization Week 2020 LSTM & World Immunization Week 2020 During World Immunization Week we celebrate vaccines and the role of vaccine researchers in Global Health. We take this opportunity to celebrate some...
-
Media BBC Radio Merseyside's SciFri with Rachel Byrne MRC/DTP PhD candidate BBC Radio Merseyside's SciFri with Rachel Byrne MRC/DTP PhD candidate LSTM’s Rachel Byrne featured on SciFri on the 3rd April at 7:05am. Rachel talks about her work supporting the Covid-19 research efforts at LSTM.
-
News article LSTM begins the validation process for the Mologic COVID-19 point-of-need diagnostic test LSTM begins the validation process for the Mologic COVID-19 point-of-need diagnostic test Independent assessment and validation of COVID-19 diagnostic test has been initiated at LSTM by Dr. Emily Adams and her research group, along with...
-
News article “Antibodies will make a significant contribution to design effective control strategies for COVID-19” “Antibodies will make a significant contribution to design effective control strategies for COVID-19” LSTM’s Professor Richard Pleass has been interviewed by ProteoGenix about how his ground-breaking work leveraging the Fc region of antibodies could...
-
News article LSTM’s HiVE Innovation programme celebrates its inaugural cohort LSTM’s HiVE Innovation programme celebrates its inaugural cohort On 3rd March, guests gathered in Accra, Ghana, to celebrate the achievements of the inaugural cohort of the Health Innovation in a Virtual...
-
News article Missed the LSTM Seminar on Tiny Targets – from a research project to large scale vector control implementation? Watch it here Missed the LSTM Seminar on Tiny Targets – from a research project to large scale vector control implementation? Watch it here
-
News article LSTM's Dr Ryan Robinson nominated in the 2020 North West Research and Innovation Awards LSTM's Dr Ryan Robinson nominated in the 2020 North West Research and Innovation Awards Clinical Research Fellow at LSTM, Dr Ryan Robinson, has been nominated for a Rising Star award for 2020 North West Research and Innovation Awards.
Latest
-
News article10 Feb 2021
-
News article8 Feb 2021
-
Blog4 Feb 2021
-
News article4 Feb 2021
-
News article3 Feb 2021
-
News article26 Jan 2021
-
News article13 Jan 2021
-
News article24 Dec 2020
-
News article17 Dec 2020
-
News article10 Dec 2020
-
News article9 Dec 2020
-
News article26 Nov 2020
-
News article27 Oct 2020
-
News article16 Oct 2020
-
News article14 Sep 2020
-
News article18 Jun 2020
-
Blog11 Jun 2020
-
News article22 May 2020
-
Blog18 May 2020
-
News article13 May 2020
-
News article27 Apr 2020
-
Blog20 Apr 2020
-
Media3 Apr 2020
-
News article27 Mar 2020
Researchers
-
Professor Giancarlo Biagini Head of the Department of Tropical Disease Biology
Areas of interest: Drug Discovery, Pharmacology, Biochemistry and Physiology of human pathogens Plasmodium falciparum and Mycobacterium tuberculosis. -
Professor Nicholas Casewell Head of Centre for Snakebite Research & Interventions, Chair in Tropical Disease Biology & Wellcome Trust Research Fellow
Areas of interest: Characterising the functional activity of venoms and developing new treatments to... -
Professor Richard J. Pleass Chair in Parasite Immunology
Areas of interest Structure and function of antibodies and their Fc-receptors in immunity to parasites. Background Richard Pleass graduated in Zoology from King’s... -
Rachel Louise Byrne MRC CASE PhD candidate
Areas of interest: molecular diagnostics, COVID-19, AMR, PCR -
Professor Penelope Phillips-Howard
Areas of interest: Public health epidemiologist, Menstrual Health Management, Adolescent health, Sexual and reproductive health, Social equity, non-communicative diseases and malaria. -
Dr Joseph Turner Reader in Infection Biology
Areas of interest: Drugs and diagnostics filariasis immunopathology neglected tropical diseases schistosomiasis COVID -
Dominic Wooding Research Technician
Areas of interest: COVID-19 Diagnostics HIV Vaccine Research Antimicrobial Resistance Malaria Neglected Tropical Diseases -
Sophie Owen PhD Student
Before I joined LSTM in 2017, I worked as a research assistant in the Department of Oncology at the University of Oxford researching the pathogenesis of sepsis. I initially trained in biomedical science (BSc, The University of... -
Dr Amy Marriott Post-Doctoral Research Associate
Areas of interest: Human filariasis, veterinary heart worm, drug models, drug discovery, Wolbachia, models reducing animal usage in scientific research -
Dr Grant Hughes Reader and Wolfson Fellow
Grant’s PhD research at The University of Queensland focused on developing a symbiotic control strategy of an agricultural disease caused by a viral pathogen transmitted by Planthoppers. To further his expertise in... -
Dr Lisa Baldwin Senior Business Manager
Areas of interest: industry academic links, translational research, diagnostics -
Dr Emily Adams Reader in Diagnostics for Infectious Diseases
Areas of interest: Diagnostics development, evaluation and implementation; Kinetoplastid diseases including Visceral Leishmaniasis, Cutaneous Leishmaniasis, Chagas and HAT. -
Dr Becky Jones-Phillips Senior Business Development Manager
Areas of interest: Commercial Translation Translational Research Industry Engagement Business Development